In a previous study, we developed and validated a radiomics nomogram by incorporating pretreatment contrast-enhanced computed tomography images and clinical factors to estimate the efficacy of anti-PD-1 antibodies treatment in patients with advanced HCC (22). This evidence concerns the gene PDCD1 and hepatocellular carcinoma.